Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- Jarrow Formulas, Inc. Unveils Pressure Optimizer(TM), With AmealPeptide(TM), a Patented Extract of Hydrolyzed Casein
Company announces the introduction of Pressure Optimizer(TM), with primary constituent is AmealPeptide(TM), a patented extract of hydrolyzed casein that contains two tripeptides (Valyl-Prolyl-Proline, Isoleucyl-Prolyl-Proline) extensively clinically studied for their effect on blood pressure.
- Jarrow Formulas, Inc. Unveils Pressure Optimizer(TM), With AmealPeptide(TM), a Patented Extract of Hydrolyzed Casein
Company announces the introduction of Pressure Optimizer(TM), with primary constituent is AmealPeptide(TM), a patented extract of hydrolyzed casein that contains two tripeptides (Valyl-Prolyl-Proline, Isoleucyl-Prolyl-Proline) extensively clinically studied for their effect on blood pressure.
- Jarrow Formulas, Inc. Unveils Pressure Optimizer(TM), With AmealPeptide(TM), a Patented Extract of Hydrolyzed Casein
Company announces the introduction of Pressure Optimizer(TM), with primary constituent is AmealPeptide(TM), a patented extract of hydrolyzed casein that contains two tripeptides (Valyl-Prolyl-Proline, Isoleucyl-Prolyl-Proline) extensively clinically studied for their effect on blood pressure.
- Jarrow Formulas, Inc. Unveils Pressure Optimizer(TM), With AmealPeptide(TM), a Patented Extract of Hydrolyzed Casein
Company announces the introduction of Pressure Optimizer(TM), with primary constituent is AmealPeptide(TM), a patented extract of hydrolyzed casein that contains two tripeptides (Valyl-Prolyl-Proline, Isoleucyl-Prolyl-Proline) extensively clinically studied for their effect on blood pressure.
- Jarrow Formulas, Inc. Unveils Pressure Optimizer(TM), With AmealPeptide(TM), a Patented Extract of Hydrolyzed Casein
Company announces the introduction of Pressure Optimizer(TM), with primary constituent is AmealPeptide(TM), a patented extract of hydrolyzed casein that contains two tripeptides (Valyl-Prolyl-Proline, Isoleucyl-Prolyl-Proline) extensively clinically studied for their effect on blood pressure.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S.
Atrium Biotechnologies Inc. has acquired HVL Inc., whose main brand is Douglas Laboratories for the total amount of $107 million ($US 92 million), approximately 6.4 times the adjusted EBITDA generated by Douglas.
- AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S.
Atrium Biotechnologies Inc. has acquired HVL Inc., whose main brand is Douglas Laboratories for the total amount of $107 million ($US 92 million), approximately 6.4 times the adjusted EBITDA generated by Douglas.
- AEterna Zentaris subsidiary, Atrium Biotechnologies, acquires Douglas Laboratories in the U.S.
Atrium Biotechnologies Inc. has acquired HVL Inc., whose main brand is Douglas Laboratories for the total amount of $107 million ($US 92 million), approximately 6.4 times the adjusted EBITDA generated by Douglas.
- Health Wright Products Announces Major Expansion
Company announces the acquisition and development of a new 120,350 square foot facility in Clackamas, OR; new facility is expected to be completed and fully functional in early 2006.
- Health Wright Products Announces Major Expansion
Company announces the acquisition and development of a new 120,350 square foot facility in Clackamas, OR; new facility is expected to be completed and fully functional in early 2006.
- Health Wright Products Announces Major Expansion
Company announces the acquisition and development of a new 120,350 square foot facility in Clackamas, OR; new facility is expected to be completed and fully functional in early 2006.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- 3rd Natural Health Product Research Conference: From Concept to Consumer- March 3 – 5, 2006 - Toronto, Canada
Subtitled 'From Concept to Consumer' this annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. It will be held March 3 – 5, 2006 in Toronto, Ontario, Canada.
- ORAFTI’s Synergy 1® Receives Natural Products Award
Orafti Active Food Ingredients has announced that its proprietary enriched inulin ingredient Synergy 1® has been honored as Editors’ Choice in Nutritional Outlook Magazine’s 2005 Natural Products Awards.
- ORAFTI’s Synergy 1® Receives Natural Products Award
Orafti Active Food Ingredients has announced that its proprietary enriched inulin ingredient Synergy 1® has been honored as Editors’ Choice in Nutritional Outlook Magazine’s 2005 Natural Products Awards.
- ORAFTI’s Synergy 1® Receives Natural Products Award
Orafti Active Food Ingredients has announced that its proprietary enriched inulin ingredient Synergy 1® has been honored as Editors’ Choice in Nutritional Outlook Magazine’s 2005 Natural Products Awards.
- EuroPharma® Selected As Exclusive Research And Development Team for Chicken Soup for the Soul(TM) Supplements
EuroPharma’s president Terry Lemerond has developed an exclusive line of supplements for the Chicken Soup for the Soul® brand to be marketed through a network of independent sales affiliates and direct response radio and TV advertising.
- EuroPharma® Selected As Exclusive Research And Development Team for Chicken Soup for the Soul(TM) Supplements
EuroPharma’s president Terry Lemerond has developed an exclusive line of supplements for the Chicken Soup for the Soul® brand to be marketed through a network of independent sales affiliates and direct response radio and TV advertising.
- EuroPharma® Selected As Exclusive Research And Development Team for Chicken Soup for the Soul(TM) Supplements
EuroPharma’s president Terry Lemerond has developed an exclusive line of supplements for the Chicken Soup for the Soul® brand to be marketed through a network of independent sales affiliates and direct response radio and TV advertising.
- EuroPharma® Selected As Exclusive Research And Development Team for Chicken Soup for the Soul(TM) Supplements
EuroPharma’s president Terry Lemerond has developed an exclusive line of supplements for the Chicken Soup for the Soul® brand to be marketed through a network of independent sales affiliates and direct response radio and TV advertising.
- EuroPharma® Selected As Exclusive Research And Development Team for Chicken Soup for the Soul(TM) Supplements
EuroPharma’s president Terry Lemerond has developed an exclusive line of supplements for the Chicken Soup for the Soul® brand to be marketed through a network of independent sales affiliates and direct response radio and TV advertising.
- EuroPharma® Selected As Exclusive Research And Development Team for Chicken Soup for the Soul(TM) Supplements
EuroPharma’s president Terry Lemerond has developed an exclusive line of supplements for the Chicken Soup for the Soul® brand to be marketed through a network of independent sales affiliates and direct response radio and TV advertising.
- EuroPharma® Selected As Exclusive Research And Development Team for Chicken Soup for the Soul(TM) Supplements
EuroPharma’s president Terry Lemerond has developed an exclusive line of supplements for the Chicken Soup for the Soul® brand to be marketed through a network of independent sales affiliates and direct response radio and TV advertising.
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- Bonkers(TM) Performance Teas Introduces Brain Boost With SerinAid® & Bacopa And Maximum Performance Super Energizer With AlphaSize® & Guarana
Company introduces mental performance enhancing teas that deliver useful amounts of both phosphatidylserine (PS) and alpha-glyceryl phosphoryl choline (A-GPC).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Indena's Cosmetic Fluid Extract Lines to Move to Greentech
Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A..
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
DALLAS, Dec 19, 2005 (BUSINESS WIRE) -- Celanese Corporation (CE)(FWB:CZZ) announced today that it has sold the omega-3 DHA business of its performance products segment Nutrinova to Lonza Ltd., Switzerland. Financial details of the deal were not disclosed.
The sale of DHA is in line with Celanese's overall strategy to focus on its core businesses as well as with Nutrinova's policy to focus on its core sweetener and food protection businesses.
DHA is derived entirely from micro-algae based natural sources. It is widely regarded as the most important omega -3 polyunsaturated fatty acid. There is a broad variety of applications for DHA such as dietary supplements, functional foods and specialty nutrition products.
Celanese Corporation (CE) is an integrated global producer of value-added industrial chemicals based in Dallas, Texas. The Company has four major businesses Chemical Products, Technical Polymers Ticona, Acetate Products and Performance Products with production plants in North America, Europe and Asia. In 2004, Celanese Corporation and its predecessor had combined net sales of $5.1 billion. The presentation of combined net sales of Celanese Corporation with its predecessor is not in accordance with U.S. GAAP. For more information on Celanese Corporation including a reconciliation of the combined net sales, please visit the company's web site at www.celanese.com.
Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission, copies of which are available from the Company |